Boothbay Fund Management, LLC Vista Gen Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $67,188 - $132,087	-76,351 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.14 - $2.09 $34,755 - $63,717	30,487 Added 66.47%	76,351 $95,000
Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $20,126 - $33,263	-12,052 Reduced 20.81%	45,864 $89,000
Q3 2021 Nov 15, 2021	SELL	$2.62 - $3.45 $182,095 - $239,781	-69,502 Reduced 54.55%	57,916 $159,000
Q2 2021 Aug 16, 2021	SELL	$1.96 - $3.15 $339,666 - $545,891	-173,299 Reduced 57.63%	127,418 $401,000

Q1 2021 May 17, 2021	SELL	$1.89 - $2.96 $315,098 - $493,488	-166,719 Reduced 35.67%	300,717 $641,000
Q4 2020 Feb 12, 2021	BUY	$0.65 - $1.94 $303,833 - $906,825	467,436 New	467,436 $907,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.